An official website of the United States government
PAR-25-103 - Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes | NOT-CA-25-035 | NCI | Jan 17, 2025 | Sep 9, 2025 | U34, R34, R03, R01, R21, P01 |
| Notice of Special Interest (NOSI): Research on rare cancers across the cancer control continuum | NOT-CA-25-010 | NCI | Dec 30, 2024 | Sep 9, 2025 | R01, R03, R21, U34, R34, P01 |
| Notice of Special Interest (NOSI): Survivorship Research for People Living with Advanced and Metastatic Cancers | NOT-CA-25-024 | NCI | Dec 17, 2024 | Sep 9, 2025 | U34, R34, R01, R03, R21, P01 |
| Notice of Special Interest (NOSI): Factors impacting how Time-Restricted Eating (TRE) influences cancer-related outcomes | NOT-CA-24-073 | NCI | Jul 9, 2024 | Sep 9, 2025 | R01, U34, K22, R21, K99/R00, K08, R34 |
For technical issues E-mail OER Webmaster